AMPIO PHARMACEUTICALS INC (AMPE) Stock Price, Quote, News and Overview
NYSEARCA:AMPE - NYSE Arca - US03209T3077 - Common Stock - Currency: USD
AMPE Quote, Performance and Key Statistics
NYSEARCA:AMPE (4/12/2024, 8:04:00 PM)
0.62
-0.09 (-12.91%)
The current stock price of AMPE is 0.62 USD. In the past month the price decreased by -62.2%. In the past year, price decreased by -84.61%.
AMPE Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| LLY | ELI LILLY & CO | 67.21 | 829.40B | ||
| NVO | NOVO-NORDISK A/S-SPONS ADR | 27.53 | 390.99B | ||
| JNJ | JOHNSON & JOHNSON | 16.25 | 390.76B | ||
| AZN | ASTRAZENECA PLC-SPONS ADR | 20.56 | 230.17B | ||
| MRK | MERCK & CO. INC. | 11.71 | 226.40B | ||
| NVS | NOVARTIS AG-SPONSORED ADR | 13.77 | 215.98B | ||
| PFE | PFIZER INC | 8.46 | 149.04B | ||
| SNY | SANOFI-ADR | 13.62 | 136.54B | ||
| BMY | BRISTOL-MYERS SQUIBB CO | 48.97 | 113.23B | ||
| GSK | GSK PLC-SPON ADR | 7.81 | 74.77B | ||
| ZTS | ZOETIS INC | 27.1 | 72.39B | ||
| TAK | TAKEDA PHARMACEUTIC-SP ADR | 31.95 | 44.58B |
Related stock screener links
About AMPE
Company Profile
Ampio Pharmaceuticals Inc is a US-based company operating in Pharmaceuticals industry. The company is headquartered in Englewood, Colorado and currently employs 8 full-time employees. The company went IPO on 2011-05-19. Ampio Pharmaceuticals, Inc. is a biopharmaceutical company. The firm is focused on the preclinical development of AR-300, and is conducting studies to evaluate the efficacy of AR-300 in osteoarthritis-related pain. The firm is primarily targeting the clinical development of AR-300 for the treatment of osteoarthritis of the knee (OAK). AR-300 is a small-molecule formulation that has demonstrated anti-inflammatory properties in vitro and protection of cartilage in preclinical rat meniscal tear studies.
Company Info
AMPIO PHARMACEUTICALS INC
9800 Mount Pyramid Court, Suite 400
Englewood COLORADO 80112 US
CEO: Michael Macaluso
Employees: 8
Company Website: https://ampiopharma.com/
Phone: 17204376500
AMPIO PHARMACEUTICALS INC / AMPE FAQ
What is the stock price of AMPIO PHARMACEUTICALS INC today?
The current stock price of AMPE is 0.62 USD. The price decreased by -12.91% in the last trading session.
What is the ticker symbol for AMPIO PHARMACEUTICALS INC stock?
The exchange symbol of AMPIO PHARMACEUTICALS INC is AMPE and it is listed on the NYSE Arca exchange.
On which exchange is AMPE stock listed?
AMPE stock is listed on the NYSE Arca exchange.
What is the price forecast or stock price prediction for AMPIO PHARMACEUTICALS INC stock?
6 analysts have analysed AMPE and the average price target is 2.04 USD. This implies a price increase of 229.03% is expected in the next year compared to the current price of 0.62. Check the AMPIO PHARMACEUTICALS INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is AMPIO PHARMACEUTICALS INC worth?
AMPIO PHARMACEUTICALS INC (AMPE) has a market capitalization of 514.60K USD. This makes AMPE a Nano Cap stock.
How many employees does AMPIO PHARMACEUTICALS INC have?
AMPIO PHARMACEUTICALS INC (AMPE) currently has 8 employees.
What are the support and resistance levels for AMPIO PHARMACEUTICALS INC (AMPE) stock?
AMPIO PHARMACEUTICALS INC (AMPE) has a resistance level at 0.9. Check the full technical report for a detailed analysis of AMPE support and resistance levels.
Should I buy AMPIO PHARMACEUTICALS INC (AMPE) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of AMPE, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of AMPE, evaluating the profitability, health, valuation and growth aspects
- AMPIO PHARMACEUTICALS INC (AMPE) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- AMPIO PHARMACEUTICALS INC (AMPE) Sales and EPS estimates to see what analysts future expectations are.
- AMPIO PHARMACEUTICALS INC (AMPE) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- AMPIO PHARMACEUTICALS INC (AMPE) Insider and Institutional Ownership to learn about the owners and their transactions.
- AMPIO PHARMACEUTICALS INC (AMPE) Stock Chart to make your own analysis
- AMPIO PHARMACEUTICALS INC (AMPE) Latest news and press-releases to stay up to date.
Does AMPIO PHARMACEUTICALS INC (AMPE) stock pay dividends?
AMPE does not pay a dividend.
When does AMPIO PHARMACEUTICALS INC (AMPE) report earnings?
AMPIO PHARMACEUTICALS INC (AMPE) will report earnings on 2024-05-06, after the market close.
What is the Price/Earnings (PE) ratio of AMPIO PHARMACEUTICALS INC (AMPE)?
AMPIO PHARMACEUTICALS INC (AMPE) does not have a PE ratio as the earnings reported over the last twelve months were negative (-11.13).
What is the Short Interest ratio of AMPIO PHARMACEUTICALS INC (AMPE) stock?
The outstanding short interest for AMPIO PHARMACEUTICALS INC (AMPE) is 0.01% of its float. Check the ownership tab for more information on the AMPE short interest.
AMPE Technical Analysis
AMPE Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to AMPE. AMPE scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.
AMPE Financial Highlights
Over the last trailing twelve months AMPE reported a non-GAAP Earnings per Share(EPS) of -11.13. The EPS increased by 48.86% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -150.51% | ||
| ROE | -256.93% | ||
| Debt/Equity | 0 |
AMPE Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 43% to AMPE. The Buy consensus is the average rating of analysts ratings from 6 analysts.